ClinicalMetric / Countries / Japan / metabolic dysfunction associated steatohepatitis mash
← 🇯🇵 Japan Trials
🇯🇵 Japan Country × Condition

metabolic dysfunction associated steatohepatitis mash Clinical Trials in Japan

Active clinical trials for metabolic dysfunction associated steatohepatitis mash with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 2 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇯🇵 Japan

Active Trials in Japan (1)

NCT05519475 Phase 2
Recruiting

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Enrollment
120 pts
Country
🇯🇵 Japan
Regeneron Pharmaceuticals
View Trial →

Frequently Asked Questions

How many metabolic dysfunction associated steatohepatitis mash clinical trials are active in Japan?
There are currently 1 active clinical trials for metabolic dysfunction associated steatohepatitis mash with sites in Japan, of which 1 are actively recruiting patients.
How can I join a metabolic dysfunction associated steatohepatitis mash clinical trial in Japan?
To join a metabolic dysfunction associated steatohepatitis mash clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are metabolic dysfunction associated steatohepatitis mash trials in Japan?
Active metabolic dysfunction associated steatohepatitis mash trials in Japan span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Japan Trials → Global metabolic dysfunction associated steatohepatitis mash Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology